Glycopyrrolate Overview Categories 1 Drugs used in anesthesia1.3 preoperative medication and sedation 17 Gastrointestinal drugs17.5 Antispasmodics 20 Muscle relaxants and cholinesterase inhibitors Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Glycopyrrolate Manufacturers of Glycopyrrolate Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Glycopyrrolate's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 200 to 400 ug300 (300)As recommended.IM,IVAs Premedication10 to 15 ug/ kg Neostigmine12 (12.5)As recommended.IVFor control of Muscranic side effects of Neostigmine in reversal of competitive neuromuscular block0.25 to 0.5 %0.38 (0.375)As recommended.Topical(cream)For Hyperhidrosis Paedriatic Dosage (20kg) 4.4 to 8.8 ug/kg6.6 (6.6)As recommended.Intra Muscular0.5-1 hr before induction of anaesthesia, as required . To maximum of 200 ug.4.4 to 8.8 ug/kg6.6 (6.6)As recommended.Intra Venous0.5-1 hr before induction of anaesthesia, as required Neonatal Dosage (3kg) 4.4 to 8.8 ug/kg6.6 (6.6)As recommended.Intra Muscular0.5-1 hr before induction of anaesthesia, as required4.4 to 8.8 ug/kg6.6 (6.6)As recommended.Intra Venous0.5-1 hr before induction of anaesthesia, as required High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Glycopyrrolate Back to top Manufacturers of Glycopyrrolate in Pakistan Brookes Back to top Previous Drug Generic - Next Drug Generic